Rafael Holdings, Inc.
A healthcare holding company in Newark, New Jersey, Rafael Holdings backs early-stage drug and medical-device ventures, with its lead therapy Trappsol® Cyclo™ in late-stage trials for the rare Niemann-Pick type C1 disease and the FDA-cleared VECTR System for ligament-release surgery. It was spun off in 2018 from IDT Corporation, the telecom run by Howard Jonas. Its name comes from the Hebrew for "God heals" — fitting for a company built around medicines.
Granted 142.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Jonas Howard SExec Chairman, CEO & President, Director, 10% owner · 3 transactions | +0.8% | 14.99M | 142.9K | — | — |
| Polinsky DavidChief Financial Officer · 2 transactions | -1.5% | 299.1K | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.